{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T19:15:01Z","timestamp":1786994101762,"version":"build-2736575974"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T00:00:00Z","timestamp":1480550400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T00:00:00Z","timestamp":1480550400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Medical Hypotheses"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1016\/j.mehy.2016.09.022","type":"journal-article","created":{"date-parts":[[2016,9,30]],"date-time":"2016-09-30T21:06:25Z","timestamp":1475269585000},"page":"16-21","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"special_numbering":"C","title":["A hypothesis on the mechanism of action of high-dose thyroid in refractory mood disorders"],"prefix":"10.1016","volume":"97","author":[{"given":"Tammas","family":"Kelly","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.mehy.2016.09.022_b0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.jad.2014.04.022","article-title":"A favorable risk-benefit analysis of High dose thyroid for treatment of bipolar disorders with regard to osteoporosis","author":"Kelly","year":"2014","journal-title":"J Affect Disord"},{"key":"10.1016\/j.mehy.2016.09.022_b0010","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.jad.2015.01.016","article-title":"An examination of myth: a favorable cardiovascular risk-benefit analysis of high-dose thyroid for affective disorders","volume":"177","author":"Kelly","year":"2015","journal-title":"J Affect Disord"},{"key":"10.1016\/j.mehy.2016.09.022_b0015","doi-asserted-by":"crossref","DOI":"10.1038\/sj.mp.4000963","article-title":"Thyroid hormones, serotonin and mood: of synergy and significance in the adult brain","volume":"7","author":"Bauer","year":"2002","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.mehy.2016.09.022_b0020","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1001\/archpsyc.1981.01780260108012","article-title":"A hypothesis of thyroid-catecholamine-receptor interaction: its relevance to affective illness","volume":"38","author":"Whybrow","year":"1981","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.mehy.2016.09.022_b0025","doi-asserted-by":"crossref","DOI":"10.4061\/2011\/306367","article-title":"Thyroid functions and bipolar affective disorder","volume":"2011","author":"Chakrabarti","year":"2011","journal-title":"J Thyroid Res"},{"key":"10.1016\/j.mehy.2016.09.022_b0030","article-title":"Levothyroxine effects on depressive symptoms and limbic glucose metabolism in bipolar disorder: a randomized, placebo-controlled positron emission tomography study","author":"Bauer","year":"2015","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.mehy.2016.09.022_b0035","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/S0893-133X(97)00181-4","article-title":"Treatment of refractory depression with high-dose thyroxine","volume":"18","author":"Bauer","year":"1998","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.mehy.2016.09.022_b0040","first-page":"49","article-title":"Clinical applications of levothyroxine in refractory mood disorders","volume":"2","author":"Bauer","year":"2003","journal-title":"Clin Appl Bipolar Disord"},{"key":"10.1016\/j.mehy.2016.09.022_b0045","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1038\/sj.mp.4001647","article-title":"Supraphysiological doses of levothyroxine alter regional cerebral metabolism and improve mood in bipolar depression","volume":"10","author":"Bauer","year":"2005","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.mehy.2016.09.022_b0050","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.jad.2008.12.010","article-title":"The use of triiodothyronine as an augmentation agent in treatment-resistant bipolar II and bipolar disorder NOS","volume":"116","author":"Kelly","year":"2009","journal-title":"J Affect Disord"},{"key":"10.1016\/j.mehy.2016.09.022_b0055","series-title":"Texas medication algorithm project procdural manual, bipolar disorder algorithms","author":"Crismon","year":"2007"},{"key":"10.1016\/j.mehy.2016.09.022_b0060","series-title":"Guideline watch: practice guideline for the treatment of patients with bipolar disorder","author":"Hirschfeld","year":"2010"},{"key":"10.1016\/j.mehy.2016.09.022_b0065","first-page":"1","article-title":"The expert consensus guideline series: medication treatment of bipolar disorder","volume":"1","author":"Sachs","year":"2000","journal-title":"Postgrad Med"},{"key":"10.1016\/j.mehy.2016.09.022_b0070","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/bdi.12025","article-title":"Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2013","volume":"15","author":"Yatham","year":"2013","journal-title":"Bipolar Disord"},{"key":"10.1016\/j.mehy.2016.09.022_b0075","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/S0002-9343(89)80614-X","article-title":"Graves\u2019 disease: an analysis of thyroid hormone levels and hyperthyroid signs and symptoms","volume":"87","author":"Trzepacz","year":"1989","journal-title":"Am J Med"},{"key":"10.1016\/j.mehy.2016.09.022_b0080","series-title":"Williams textbook of endocrinology","first-page":"362","article-title":"Thyrotoxicosis","author":"Mandel","year":"2011"},{"key":"10.1016\/j.mehy.2016.09.022_b0085","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1089\/thy.2010.0417","article-title":"Hyperthyroidism and other causes of thyrotoxicosis: management guidelines of the American Thyroid Association and American Association of Clinical Endocrinologists","volume":"21","author":"Bahn","year":"2011","journal-title":"Thyroid"},{"key":"10.1016\/j.mehy.2016.09.022_b0090","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.3923\/pjbs.2010.1066.1076","article-title":"A review on hyperthyroidism: thyrotoxicosis under surveillance","volume":"13","author":"Mansourian","year":"2010","journal-title":"Pak J Biol Sci"},{"key":"10.1016\/j.mehy.2016.09.022_b0095","first-page":"209","article-title":"Administration of high dose levothyroxine in treatment of rapid cycling bipolar disorders. Review of the literature and initial therapeutic application apropos of 6 cases","volume":"23","author":"Afflelou","year":"1996","journal-title":"L\u2019Encephale"},{"key":"10.1016\/j.mehy.2016.09.022_b0100","doi-asserted-by":"crossref","DOI":"10.1176\/appi.ajp.157.10.1704-a","article-title":"High doses of levothyroxine for refractory rapid cycling","author":"Extein","year":"2000","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.mehy.2016.09.022_b0105","doi-asserted-by":"crossref","first-page":"59","DOI":"10.3109\/15622970109027495","article-title":"Thyroid hormone, neural tissue and mood modulation","volume":"2","author":"Bauer","year":"2001","journal-title":"World J Biol Psychiatry"},{"key":"10.1016\/j.mehy.2016.09.022_b0110","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/S0165-0327(00)00363-3","article-title":"Effects of supraphysiological thyroxine administration in healthy controls and patients with depressive disorders","volume":"68","author":"Bauer","year":"2002","journal-title":"J Affect Disord"},{"key":"10.1016\/j.mehy.2016.09.022_b0115","doi-asserted-by":"crossref","first-page":"e89","DOI":"10.1016\/j.jad.2011.06.011","article-title":"Long-term treatment with supraphysiological doses of thyroid hormone in affective disorders\u2014effects on bone mineral density","volume":"136","author":"Ricken","year":"2012","journal-title":"J Affect Disord"},{"key":"10.1016\/j.mehy.2016.09.022_b0120","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1001\/archpsyc.1990.01810170035006","article-title":"Rapid cycling bipolar affective disorder: II. Treatment of refractory rapid cycling with high-dose levothyroxine: a preliminary study","volume":"47","author":"Bauer","year":"1990","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.mehy.2016.09.022_b0125","doi-asserted-by":"crossref","first-page":"162","DOI":"10.4088\/JCP.12m08305","article-title":"Supraphysiologic doses of levothyroxine as adjunctive therapy in bipolar depression: a randomized, double-blind, placebo-controlled study","volume":"75","author":"Stamm","year":"2014","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.mehy.2016.09.022_b0130","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/bdi.12025","article-title":"Canadian network for mood and anxiety treatments (CANMAT) and international society for bipolar disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2013","volume":"15","author":"Yatham","year":"2013","journal-title":"Bipolar Disord"},{"key":"10.1016\/j.mehy.2016.09.022_b0135","doi-asserted-by":"crossref","first-page":"S549","DOI":"10.2188\/jea.JE20090224","article-title":"Calcium intake and associated factors in a general Japanese population: baseline data of NIPPON DATA80\/90 and the National Nutrition Survey","volume":"20","author":"Higashiguchi","year":"2009","journal-title":"J Epidemiol\/Jpn Epidemiol Assoc"},{"key":"10.1016\/j.mehy.2016.09.022_b0140","doi-asserted-by":"crossref","first-page":"S95","DOI":"10.4103\/2230-8210.83333","article-title":"Why are our hypothyroid patients unhappy? Is tissue hypothyroidism the answer?","volume":"15","author":"Kalra","year":"2011","journal-title":"Indian J Endocrinol Metab"},{"key":"10.1016\/j.mehy.2016.09.022_b0145","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1210\/edrv.22.4.0435","article-title":"Plasma membrane transport of thyroid hormones and its role in thyroid hormone metabolism and bioavailability","volume":"22","author":"Hennemann","year":"2001","journal-title":"Endocr Rev"},{"key":"10.1016\/j.mehy.2016.09.022_b0150","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1007\/s00249-013-0921-1","article-title":"Site-specific basicities regulate molecular recognition in receptor binding: in silico docking of thyroid hormones","volume":"42","author":"T\u00f3th","year":"2013","journal-title":"Eur Biophys J"},{"issue":"2008","key":"10.1016\/j.mehy.2016.09.022_b0155","first-page":"1644","article-title":"Absorption, transport and bio-availability of iodothyronines","volume":"133","author":"Dietrich","year":"1946","journal-title":"Dtsch Med Wochenschr"},{"key":"10.1016\/j.mehy.2016.09.022_b0160","doi-asserted-by":"crossref","first-page":"53","DOI":"10.14200\/jrm.2014.3.0104","article-title":"Thyroid hormone transport into cellular tissue","volume":"3","author":"Holtorf","year":"2014","journal-title":"J Restor Med"},{"key":"10.1016\/j.mehy.2016.09.022_b0165","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.beem.2007.04.001","article-title":"Thyroid hormone transporters in health and disease: advances in thyroid hormone deiodination","volume":"21","author":"K\u00f6hrle","year":"2007","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"10.1016\/j.mehy.2016.09.022_b0170","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1089\/thy.1996.6.359","article-title":"Different regulation of thyroid hormone transport in liver and pituitary: its possible role in the maintenance of low T3 production during nonthyroidal illness and fasting in man","volume":"6","author":"Everts","year":"1996","journal-title":"Thyroid"},{"key":"10.1016\/j.mehy.2016.09.022_b0175","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1677\/joe.0.1650599","article-title":"Thyroid hormone uptake in cultured rat anterior pituitary cells: effects of energy status and bilirubin","volume":"165","author":"Wassen","year":"2000","journal-title":"J Endocrinol"},{"key":"10.1016\/j.mehy.2016.09.022_b0180","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1210\/endo-114-1-280","article-title":"Reduced triiodothyronine content in liver but not pituitary of the uremic rat model: demonstration of changes compatible with thyroid hormone deficiency in liver only","volume":"114","author":"Lim","year":"1984","journal-title":"Endocrinology"},{"key":"10.1016\/j.mehy.2016.09.022_b0185","doi-asserted-by":"crossref","first-page":"E156","DOI":"10.1152\/ajpendo.1986.251.2.E156","article-title":"Effects of caloric deprivation on thyroid hormone tissue uptake and generation of low-T3 syndrome","volume":"251","author":"van der Heyden","year":"1986","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.mehy.2016.09.022_b0190","first-page":"370","article-title":"Mitochondrial dysfunction and psychiatric disorders","volume":"32","author":"Jou","year":"2009","journal-title":"Chang Gung Med J"},{"key":"10.1016\/j.mehy.2016.09.022_b0195","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1007\/s11064-008-9865-8","article-title":"Mitochondrial dysfunction and psychiatric disorders","volume":"34","author":"Rezin","year":"2009","journal-title":"Neurochem Res"},{"key":"10.1016\/j.mehy.2016.09.022_b0200","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1038\/nrn3229","article-title":"Impaired mitochondrial function in psychiatric disorders","volume":"13","author":"Manji","year":"2012","journal-title":"Nat Rev Neurosci"},{"key":"10.1016\/j.mehy.2016.09.022_b0205","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1038\/sj.mp.4001711","article-title":"Mitochondrial dysfunction in bipolar disorder: evidence from magnetic resonance spectroscopy research","volume":"10","author":"Stork","year":"2005","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.mehy.2016.09.022_b0210","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1139\/jpn.0623","article-title":"Downregulation in components of the mitochondrial electron transport chain in the postmortem frontal cortex of subjects with bipolar disorder","volume":"31","author":"Sun","year":"2006","journal-title":"J Psychiatry Neurosci JPN"},{"key":"10.1016\/j.mehy.2016.09.022_b0215","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.jad.2014.04.025","article-title":"Increased platelet intracellular calcium ion concentration is specific to bipolar disorder","volume":"164","author":"Dubovsky","year":"2014","journal-title":"J Affect Disord"},{"key":"10.1016\/j.mehy.2016.09.022_b0220","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1046\/j.1365-2265.1998.00377.x","article-title":"The significance of plasma membrane transport in the bioavailability of thyroid hormone","volume":"48","author":"Hennemann","year":"1998","journal-title":"Clin Endocrinol Oxford"},{"key":"10.1016\/j.mehy.2016.09.022_b0225","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1210\/jc.2002-021260","article-title":"Classification of thyroid diseases: suggestions for a revision","volume":"88","author":"Monaco","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.mehy.2016.09.022_b0230","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jad.2011.12.049","article-title":"Can bipolar disorder be viewed as a multi-system inflammatory disease?","volume":"141","author":"Leboyer","year":"2012","journal-title":"J Affect Disord"},{"key":"10.1016\/j.mehy.2016.09.022_b0235","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/j.psyneuen.2010.01.005","article-title":"Thyroid axis activity and suicidal behavior in depressed patients","volume":"35","author":"Duval","year":"2010","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.mehy.2016.09.022_b0240","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1210\/en.2008-1518","article-title":"Pathophysiological importance of thyroid hormone transporters","volume":"150","author":"Heuer","year":"2009","journal-title":"Endocrinology"},{"key":"10.1016\/j.mehy.2016.09.022_b9000","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pnpbp.2016.06.001","article-title":"Elevated levels of circulating thyroid hormone do not cause the medical sequelae of hyperthyroidism","volume":"71","author":"Kelly","year":"2016","journal-title":"Prog Neuro-Psychoph and Biological Psychiatry"}],"container-title":["Medical Hypotheses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306987716302742?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306987716302742?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,5]],"date-time":"2025-10-05T19:13:57Z","timestamp":1759691637000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306987716302742"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12]]},"references-count":49,"alternative-id":["S0306987716302742"],"URL":"https:\/\/doi.org\/10.1016\/j.mehy.2016.09.022","relation":{},"ISSN":["0306-9877"],"issn-type":[{"value":"0306-9877","type":"print"}],"subject":[],"published":{"date-parts":[[2016,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A hypothesis on the mechanism of action of high-dose thyroid in refractory mood disorders","name":"articletitle","label":"Article Title"},{"value":"Medical Hypotheses","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mehy.2016.09.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}